093_HB1268eng HB1268 Engrossed LRB093 05340 DRJ 06191 b 1 AN ACT in relation to public aid. 2 Be it enacted by the People of the State of Illinois, 3 represented in the General Assembly: 4 Section 5. The Illinois Public Aid Code is amended by 5 changing Section 5-5.12 as follows: 6 (305 ILCS 5/5-5.12) (from Ch. 23, par. 5-5.12) 7 Sec. 5-5.12. Pharmacy payments. 8 (a) Every request submitted by a pharmacy for 9 reimbursement under this Article for prescription drugs 10 provided to a recipient of aid under this Article shall 11 include the name of the prescriber or an acceptable 12 identification number as established by the Department. 13 (b) Pharmacies providing prescription drugs under this 14 Article shall be reimbursed at a rate which shall include a 15 professional dispensing fee as determined by the Illinois 16 Department, plus the current acquisition cost of the 17 prescription drug dispensed. The Illinois Department shall 18 update its information on the acquisition costs of all 19 prescription drugs no less frequently than every 30 days. 20 However, the Illinois Department may set the rate of 21 reimbursement for the acquisition cost, by rule, at a 22 percentage of the current average wholesale acquisition cost. 23 (c) Reimbursement under this Article for prescription 24 drugs shall be limited to reimbursement for 4 brand-name 25 prescription drugs per patient per month. This subsection 26 applies only if (i) the brand-name drug was not prescribed 27 for an acute or urgent condition, (ii) the brand-name drug 28 was not prescribed for Alzheimer's disease, arthritis, 29 diabetes, HIV/AIDS, a mental health condition, or respiratory 30 disease, and (iii) a therapeutically equivalent generic 31 medication has been approved by the federal Food and Drug HB1268 Engrossed -2- LRB093 05340 DRJ 06191 b 1 Administration. 2 (d) The Department shall not impose requirements for 3 prior approval based on a preferred drug list for 4 anti-retroviral, anti-hemophilic factor concentrates, or any 5 atypical antipsychotics, conventional antipsychotics, or 6 anticonvulsants used for the treatment of serious mental 7 illnesses until 30 days after it has conducted a study of the 8 impact of such requirements on patient care and submitted a 9 report to the Speaker of the House of Representatives and the 10 President of the Senate. 11 (Source: P.A. 92-597, eff. 6-28-02; 92-825, eff. 8-21-02; 12 revised 9-19-02.) 13 Section 99. Effective date. This Act takes effect upon 14 becoming law.